Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daliborka Bursać
Observed names:
Bursac, Daliborka,
Daliborka Bursac
Institutions:
University of Novi Sad,
Institute for Pulmonary Diseases of Vojvodina
Observed institutions:
University of Novi Sad,
Institute for Pulmonary Diseases of Vojvodina
ORCID:
0000-0003-4294-7043
Observed ORCID:
0000-0003-4294-7043
OpenAlex ID:
A5113857800
Lung cancer biopsies: Comparison between simple 22G, 22G upgraded and 21G needle for EBUS-TBNA
2020
·
Paul Zarogoulidis
, Dimitris Petridis
, et al.
·
Journal of Cancer
·
17
PDF
Attitudes toward Death among Health Care Professionals in the Balkan Region
2024
·
Tomi Kovacevic
, Bojan Zaric
, et al.
·
Current Oncology
·
14
Intratumoral Treatment with Chemotherapy and Immunotherapy for NSCLC with EBUS-TBNA 19G
2021
·
Paul Zarogoulidis
, Wolfgang Hohenforst-Schmidt
, et al.
·
Journal of Cancer
·
13
PDF
Efficacy of Atezolizumab in Subsequent Lines of Therapy for NSCLC Patients: Insights from Real-World Data
2024
·
Milica Kontić
, Filip Marković
, et al.
·
Cancers
·
6
Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination
2020
·
Paul Zarogoulidis
, Vagelis Christakidis
, et al.
·
Expert Review of Respiratory Medicine
·
6
Thyroid cancer diagnosis with transdermal probe 22G U/S versus EBUS-convex probe TBNA-B 22G and 19G: pros and cons
2021
·
Paul Zarogoulidis
, Haidong Huang
, et al.
·
Expert Review of Medical Devices
·
5
Actinomyces Odontolyticus - Associated Bacteremia
2012
·
Anika Považan
, Anka Vukelić
, et al.
·
Macedonian Journal of Medical Sciences
·
4
PDF
The efficacy outcomes in non-small cell lung cancer patients treated with PD axis inhibitor agents - a population-based study of the Vojvodina region
2024
·
Nensi Lalić
, Marko Bojović
, et al.
·
Pathology & Oncology Research
·
3
PDF
Myocardial Ischemia during Combined Chemotherapy with Etoposide and Cisplatin for Non-Small Cell Lung Cancer
2018
·
Daliborka Bursac
·
Oncology & Cancer Case Reports
·
3
Mortality of COVID-19 pneumonia during anticancer treatment in lung cancer patients
2022
·
Daliborka Bursac
, Bojan Zaric
, et al.
·
Vojnosanitetski pregled
·
2
PDF
Nodule Characteristics, Clinical Risk Factors, and Radiologist Experience as Predictors of Positive Baseline LDCT Screening Results
2025
·
Jelena Djekic Malbasa
, Tomi Kovacevic
, et al.
·
Healthcare
·
1
PDF
Abstract PO3-13-01: ONTARGET: Phase 3 randomized, double-blind, placebo-controlled trial evaluating crofelemer for the prophylaxis of diarrhea in adult patients with solid tumors receiving targeted therapies with or without standard chemotherapy
2024
·
Lee Schwartzberg
, Pablo Okhuysen
, et al.
·
Cancer Research
·
1
Effective Differences between 2D and 3D Planned Brachytherapy in Lung Cancer: An Institutional Retrospective Study
2024
·
Nensi Lalić
, Marko Bojović
, et al.
·
Medicina
·
1
PDF
The importance of re-biopsy in the era of molecular therapy for lung cancer
2024
·
Nensi Lalic
, Daliborka Bursac
, et al.
·
Srpski arhiv za celokupno lekarstvo
·
1
PDF
Immunotoxicity of pembrolizumab in patients with metastatic non-small cell lung cancer: A single-centre study
2024
·
Milos Stojanovic
, Daliborka Bursac
·
Archive of oncology
·
1
PDF
Personalized Approach to Tissue and Liquid Biopsy after Failure of First-Line EGFR-TKIs: Is There an Issue When Tissue Is Not the Issue? A Case Series
2021
·
Daliborka Bursac
, Bojan Zarić
, et al.
·
Case Reports in Oncology
·
1
Patient with Primary T790M Mutation in Lung Adenocarcinoma Treated with Gefitinib as a First-Line and Osimertinib as a Second-Line Therapy: A Case Report
2019
·
Daliborka Bursać
, Tatjana Šarčev
, et al.
·
Journal of Carcinogenesis & Mutagenesis
·
1
Hematological toxicity associated with gemcitabine/cisplatin in elderly non-small cell lung cancer patients
2011
·
Nevena Secen
, Danica Sazdanic-Velikic
, et al.
·
European Respiratory Journal
·
1
Effect of cardiovascular comorbidities on the survival patients with stage I and II non-small-cell lung cancer
2011
·
Daliborka Bursac
, Nevena Secen
, et al.
·
European Respiratory Journal
·
1
Real-world data survival outcomes of first line immunotherapy with pembrolizumab in high expressers with stage IV non-small cell lung cancer
2026
·
Vladimir Stojsic
, Bojan Zaric
, et al.
·
Radiology and Oncology
PDF
Lung and thoracic cancers
2026
·
Bojan Zarić
, Daliborka Bursać
, et al.
·
Elsevier eBooks
Lung cancer incidence and mortality, primary and secondary prevention: Where are we?
2025
·
Marijana Srećković
, Tihomir Dugandžija
, et al.
·
Glasnik javnog zdravlja
PDF
Cardiotoxicity of first-line chemotherapy in patients with advanced non-small cell lung cancer
2018
·
Daliborka Bursać
·
Archives in Cancer Research
Safely Chemotherapy Administration in Patient with Small-cell Lung Cancer and End-stage Renal Disease Undergoing Haemodialysis
2018
·
Daliborka Bursac
·
Journal of Carcinogenesis & Mutagenesis
Kardiotoksičnost hemioterapije prve linije(gemcitabin/cisplatin i paclitaxel/carboplatin) kod bolesnika sa uznapredovalim stadijumom nemikrocelulrnog karcinoam bronha
2017
·
Institut za plućne bolesti Vojvodine, Klinika za pulmološku onkologiju,Sremska Kamenica, Srbija
, Daliborka Bursać
, et al.
·
Respiratio
PDF
Show more works
View as search
Works count:
32
Citation count:
82
H-index:
5
I10-index:
3
Year
Topic
Type